ABSTRACT
The quality of life in patients with painful temporomandibular dysfunction and the efficiency of serotonin antidepressants as an element of therapy of these patients were evaluated. The quality of life is decreased in this patient population; they develop hypothymic reactions. Use of serotonin-positive antidepressants appreciably improved the quality of life.
Subject(s)
Quality of Life/psychology , Temporomandibular Joint Dysfunction Syndrome/psychology , Antidepressive Agents, Second-Generation/therapeutic use , Dysthymic Disorder/drug therapy , Dysthymic Disorder/etiology , Facial Pain/drug therapy , Facial Pain/psychology , Humans , Pain Measurement , Selective Serotonin Reuptake Inhibitors/therapeutic use , Temporomandibular Joint Dysfunction Syndrome/drug therapyABSTRACT
The quality of life and presence of depressions were evaluated in patients with painful temporomandibular dysfunction and the advantages of serotonin antidepressants in combined therapy of this condition were discussed. The findings indicate a decrease of the quality of life and hypothymic reactions in this category of patients. Addition of serotonin antidepressants to combined therapy appreciably improved the quality of life and more rapidly led to reduction of depressive symptoms.
